Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.22
-0.0200-0.32%
Post-market: 6.13-0.0900-1.45%17:05 EDT
Volume:728.49K
Turnover:4.57M
Market Cap:337.61M
PE:-2.53
High:6.41
Open:6.14
Low:6.11
Close:6.24
Loading ...

Emergent BioSolutions Inc: Outlook FY Total Revenues $750 Mln - $850 Mln

THOMSON REUTERS
·
04 Mar

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
04 Mar

Emergent BioSolutions Inc. (NYSE:EBS) is favoured by institutional owners who hold 64% of the company

Simply Wall St.
·
03 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Mar

Envista Smile Project Donates $1.8 Million in 2024

PR Newswire
·
26 Feb

United Opens Grab-and-Go Club in Houston

PR Newswire
·
25 Feb

DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences

ACCESS Newswire
·
19 Feb

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

GlobeNewswire
·
18 Feb

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

GlobeNewswire
·
07 Feb

Envista Reports Fourth Quarter 2024 Results

PR Newswire
·
06 Feb

Envista to hold Capital Markets Day on March 5, 2025

PR Newswire
·
05 Feb

DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025

ACCESS Newswire
·
03 Feb

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Jan

BRIEF-Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Reuters
·
16 Jan

Emergent BioSolutions Inc - First Interim Analysis of Mosa Trial Expected by End of Q1 2025

THOMSON REUTERS
·
16 Jan

Enrollment Starts in Africa Cdc-Led Mpox Therapeutic Study (Mosa)

THOMSON REUTERS
·
16 Jan

Emergent BioSolutions Shares up 4.3% on Gaining Commercial Rights for Hikma's Opioid Overdose Treatment

THOMSON REUTERS
·
14 Jan

BUZZ-Emergent up on gaining commercial rights for Hikma's opioid overdose treatment

Reuters
·
14 Jan

Emergent BioSolutions Obtains Commercial Rights to Kloxxado Nasal Spray

MT Newswires Live
·
14 Jan

Emergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray

TIPRANKS
·
14 Jan